NumerixS Investment Technologies’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-501
| Closed | -$40K | – | 251 |
|
|
2020
Q2 | $40K | Sell |
501
-1,900
| -79% | -$152K | 0.01% | 837 |
|
|
2020
Q1 | $139K | Buy |
+2,401
| New | +$139K | 0.07% | 337 |
|
|
2019
Q4 | – | Sell |
-200
| Closed | -$10K | – | 1095 |
|
|
2019
Q3 | $10K | Buy |
+200
| New | +$10K | ﹤0.01% | 938 |
|
|
2018
Q4 | – | Sell |
-1,700
| Closed | -$112K | – | 1156 |
|
|
2018
Q3 | $112K | Buy |
1,700
+400
| +31% | +$26.4K | 0.02% | 774 |
|
|
2018
Q2 | $66K | Buy |
+1,300
| New | +$66K | 0.02% | 861 |
|
|
2017
Q1 | – | Sell |
-5,900
| Closed | -$194K | – | 1200 |
|
|
2016
Q4 | $194K | Buy |
+5,900
| New | +$194K | 0.02% | 678 |
|
|
2016
Q3 | – | Sell |
-11,000
| Closed | -$309K | – | 1164 |
|
|
2016
Q2 | $309K | Buy |
+11,000
| New | +$309K | 0.04% | 556 |
|